Top Small Cap Stocks To Watch Now – May 20th

by · The Cerbat Gem

Cerebras Systems, AltC Acquisition, POET Technologies, HCW Biologics, and FREYR Battery are the five Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks are shares of publicly traded companies with relatively small market capitalizations, generally considered to be in the lower end of the market compared with large-cap companies. For stock market investors, these stocks are often seen as having higher growth potential but also greater risk and volatility than larger, more established companies. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Cerebras Systems (CBRS)

We are building the fastest AI infrastructure in the world. In AI, speed is critical to win. Speed improves user engagement, expands product capabilities, can lower operating costs, and opens new markets. It shortens iteration cycles for engineers, researchers, and professionals across industries, allowing them to be more productive.

Read Our Latest Research Report on CBRS

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

Read Our Latest Research Report on ALCC

POET Technologies (POET)

POET Technologies Inc. designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. It offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques.

Read Our Latest Research Report on POET

HCW Biologics (HCWB)

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.

Read Our Latest Research Report on HCWB

FREYR Battery (FREY)

Read Our Latest Research Report on FREY

Featured Stories